Voltage-Gated Calcium Channels as Targets for the Treatment of Chronic Pain

Peripheral Receptor Targets for Analgesia: Novel Approaches to Pain Management

Volumn , Issue , 2009, Pages 111-136

  McGivern, Joseph G ^a  

^a AMGEN INC   (United States)

Author keywords

Calcium channel auxiliary subunits; Voltage gated and ligand gated ion channels and neuronal activity control; Voltage gated calcium channel structure and diversity

Indexed keywords

EID: 84890611064     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470522226.ch5     Document Type: Chapter

References (152)

1. Berridge, M.J.(1998). Neuronal calcium signaling. Neuron 21(1), 13-26
2. McGivern, J.G., Worley, J.F.(2007). Ion channels, voltage gated. In, Triggle, D.J., Taylor, J.B. (eds.). Comprehensive Medicinal Chemistry II, Vol. 2. Elsevier , Oxford, pp. 827-875
3. Briggs, C.A., Gopalakrishnan, M.(2007). Ion channels, ligand gated. In, Triggle, D.J., Taylor, J.B. (eds.). Comprehensive Medicinal Chemistry II, Vol. 2. Elsevier , Oxford, pp. 877-918
4. Catterall, W.A., Striessnig, J., Snutch, T.P., Perez-Reyes, E.(2003). International Union of Pharmacology. XL. Compendium of voltage-gated ion channels, calcium channels. Pharmacol Rev 55(4), 579-581
5. Ertel, E.A., Campbell, K.P., Harpold, M.M., Hofmann, F., Mori, Y., Perez-Reyes, E., Schwartz, A., Snutch, T.P., Tanabe, T., Birnbaumer, L., Tsien, R.W., Catterall, W.A.(2000). Nomenclature of voltage-gated calcium channels. Neuron 25(3), 533-535
6. Sather, W.A., McCleskey, E.W.(2003). Permeation and selectivity in calcium channels. Annu Rev Physiol 65 , 133-159
7. Richards, M.W., Butcher, A.J., Dolphin, A.C.(2004). Ca2+ channel beta-subunits, structural insights AID our understanding. Trends Pharmacol Sci 25(12), 626-632
8. Long, S.B., Campbell, E.B., Mackinnon, R.(2005). Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science 309(5736), 897-903
9. Long, S.B., Campbell, E.B., Mackinnon, R.(2005). Voltage sensor of Kv1.2, structural basis of electromechanical coupling. Science 309(5736), 903-908
10. McGivern, J.G., McDonough, S.I.(2004). Voltage-gated calcium channels as targets for the treatment of chronic pain. Curr Drug Targets CNS Neurol Disord 3(6), 457-478
11. McGivern, J.G.(2006). Targeting N-type and T-type calcium channels for the treatment of pain. Drug Discov Today 11(5-6), 245-253
12. Matthews, E.A., Dickenson, A.H.(2001). Effects of spinally delivered N-and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 92(1-2), 235-246
13. Luvisetto, S., Marinelli, S., Panasiti, M.S., D ' Amato, F.R., Fletcher, C.F., Pavone, F., Pietrobon, D.(2006). Pain sensitivity in mice lacking the Ca(v)2.1alpha1 subunit of P/Q-type Ca2+ channels. Neuroscience 142(3), 823-832
14. Matthews, E.A., Bee, L.A., Stephens, G.J., Dickenson, A.H.(2007). The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain. Eur J Neurosci 25(12), 3561-3569
15. Fang, Z., Park, C.K., Li, H.Y., Kim, H.Y., Park, S.H., Jung, S.J., Kim, J.S., Monteil, A., Oh, S.B., Miller, R.J.(2007). Molecular basis of Ca(v)2.3 calcium channels in rat nociceptive neurons. J Biol Chem 282(7), 4757-4764
16. Westenbroek, R.E., Hell, J.W., Warner, C., Dubel, S.J., Snutch, T.P., Catterall, W.A.(1992). Biochemical properties and subcellular distribution of an N-type calcium channel alpha 1 subunit. Neuron 9(6), 1099-1115
17. Takemura, M., Kiyama, H., Fukui, H., Tohyama, M., Wada, H.(1989). Distribution of the omega-conotoxin receptor in rat brain. An autoradiographic mapping. Neuroscience 32(2), 405-416
18. Zamponi, G.W.(2003). Regulation of presynaptic calcium channels by synaptic proteins. J Pharmacol Sci 92(2), 79-83
19. Westenbroek, R.E., Hoskins, L., Catterall, W.A.(1998). Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J Neurosci 18(16), 6319-6330
20. Abdulla, F.A., Moran, T.D., Balasubramanyan, S., Smith, P.A.(2003). Effects and consequences of nerve injury on the electrical properties of sensory neurons. Can J Physiol Pharmacol 81(7), 663-682
21. Cizkova, D., Marsala, J., Lukacova, N., Marsala, M., Jergova, S., Orendacova, J., Yaksh, T.L.(2002). Localization of N-type Ca2+ channels in the rat spinal cord following chronic constrictive nerve injury. Exp Brain Res 147(4), 456-463
22. Lancaster, E., Oh, E.J., Gover, T., Weinreich, D.(2002). Calcium and calcium-activated currents in vagotomized rat primary vagal afferent neurons. J Physiol 540 (Pt 2), 543-556
23. Baccei, M.L., Kocsis, J.D.(2000). Voltage-gated calcium currents in axotomized adult rat cutaneous afferent neurons. J Neurophysiol 83(4), 2227-2238
24. Bell, T.J., Thaler, C., Castiglioni, A.J., Helton, T.D., Lipscombe, D.(2004). Cell-specific alternative splicing increases calcium channel current density in the pain pathway. Neuron 41(1), 127-138
25. Altier, C., Dale, C.S., Kisilevsky, A.E., Chapman, K., Castiglioni, A.J., Matthews, E.A., Evans, R.M., Dickenson, A.H., Lipscombe, D., Vergnolle, N., Zamponi, G.W.(2007). Differential role of N-type calcium channel splice isoforms in pain. J Neurosci 27(24), 6363-6373
26. Swayne, L.A., Bourinet, E.(2008). Voltage-gated calcium channels in chronic pain, emerging role of alternative splicing. Pflugers Arch 456(3), 459-466
27. Saegusa, H., Kurihara, T., Zong, S., Kazuno, A., Matsuda, Y., Nonaka, T., Han, W., Toriyama, H., Tanabe, T.(2001). Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel. EMBO J 20(10), 2349-2356
28. Kim, C., Jun, K., Lee, T., Kim, S.S., McEnery, M.W., Chin, H., Kim, H.L., Park, J.M., Kim, D.K., Jung, S.J., Kim, J., Shin, H.S.(2001). Altered nociceptive response in mice deficient in the alpha(1B) subunit of the voltage-dependent calcium channel. Mol Cell Neurosci 18(2), 235-245
29. Schroeder, C.I., Doering, C.J., Zamponi, G.W., Lewis, R.J.(2006). N-type calcium channel blockers, novel therapeutics for the treatment of pain. Med Chem 2(5), 535-543
30. Chung, D., Gaur, S., Bell, J.R., Ramachandran, J., Nadasdi, L.(1995). Determination of disulfide bridge pattern in omega-conopeptides. Int J Pept Protein Res 46(3-4), 320-325
31. McGivern, J.G.(2007). Ziconotide, a review of its pharmacology and use in the treatment of pain. Neuropsychiatr Dis Treat 3(1), 69-85
32. Stoehr, S.J., Dooley, D.J.(1993). Characteristics of [125I]omega-conotoxin MVIIA binding to rat neocortical membranes. Neurosci Lett 161(1), 113-116
33. Kristipati, R., Nadasdi, L., Tarczy-Hornoch, K., Lau, K., Miljanich, G.P., Ramachandran, J., Bell, J.R.(1994). Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channels. Mol Cell Neurosci 5(3), 219-228
34. Nielsen, K.J., Adams, D., Thomas, L., Bond, T., Alewood, P.F., Craik, D.J., Lewis, R.J.(1999). Structure-activity relationships of omega-conotoxins MVIIA, MVIIC and 14 loop splice hybrids at N and P/Q-type calcium channels. J Mol Biol 289(5), 1405-1421
35. Lewis, R.J., Nielsen, K.J., Craik, D.J., Loughnan, M.L., Adams, D.A., Sharpe, I.A., Luchian, T., Adams, D.J., Bond, T., Thomas, L., Jones, A., Matheson, J.L., Drinkwater, R., Andrews, P.R., Alewood, P.F.(2000). Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J Biol Chem 275(45), 35335-35344
36. Fox, J.A.(1995). Irreversible and reversible blockade of IMR32 calcium channel currents by synthetic MVIIA and iodinated MVIIC omega-conopeptides. Pflugers Arch 429(6), 873-875
37. Sanger, G.J., Ellis, E.S., Harries, M.H., Tilford, N.S., Wardle, K.A., Benham, C.D.(2000). Rank-order inhibition by omega-conotoxins in human and animal autonomic nerve preparations. Eur J Pharmacol 388(1), 89-95
38. Wen, L., Yang, S., Qiao, H., Liu, Z., Zhou, W., Zhang, Y., Huang, P.(2005). SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons. Br J Pharmacol 145(6), 728-739
39. Bleakman, D., Bowman, D., Bath, C.P., Brust, P.F., Johnson, E.C., Deal, C.R., Miller, R.J., Ellis, S.B., Harpold, M.M., Hans, M., Grantham, C.J.(1995). Characteristics of a human N-type calcium channel expressed in HEK293 cells. Neuropharmacology 34(7), 753-765
40. Gaur, S., Newcomb, R., Rivnay, B., Bell, J.R., Yamashiro, D., Ramachandran, J., Miljanich, G.P.(1994). Calcium channel antagonist peptides define several components of transmitter release in the hippocampus. Neuropharmacology 33(10), 1211-1219
41. Newcomb, R., Palma, A., Fox, J., Gaur, S., Lau, K., Chung, D., Cong, R., Bell, J.R., Horne, B., Nadasdi, L., Ramachandran, J.(1995). SNX-325, a novel calcium antagonist from the spider Segestria florentina. Biochemistry 34(26), 8341-8347
42. Wang, Y.X., Bezprozvannaya, S., Bowersox, S.S., Nadasdi, L., Miljanich, G., Mezo, G., Silva, D., Tarczy-Hornoch, K., Luther, R.R.(1998). Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockers. Naunyn Schmiedebergs Arch Pharmacol 357(2), 159-168
43. Smith, M.T., Cabot, P.J., Ross, F.B., Robertson, A.D., Lewis, R.J.(2002). The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 96(1-2), 119-127
44. Motin, L., Adams, D.J.(2008). Omega-conotoxin inhibition of excitatory synaptic transmission evoked by dorsal root stimulation in rat superficial dorsal horn. Neuropharmacology 55(5), 860-864
45. Malmberg, A.B., Yaksh, T.L.(1994). Voltage-sensitive calcium channels in spinal nociceptive processing, blockade of N-and P-type channels inhibits formalin-induced nociception. J Neurosci 14(8), 4882-4890
46. Malmberg, A.B., Yaksh, T.L.(1995). Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 60(1), 83-90
47. Bowersox, S.S., Gadbois, T., Singh, T., Pettus, M., Wang, Y.X., Luther, R.R.(1996). Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J Pharmacol Exp Ther 279(3), 1243-1249
48. Wang, Y.X., Gao, D., Pettus, M., Phillips, C., Bowersox, S.S.(2000). Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats. Pain 84(2-3), 271-281
49. Sluka, K.A.(1998). Blockade of N-and P/Q-type calcium channels reduces the secondary heat hyperalgesia induced by acute inflammation. J Pharmacol Exp Ther 287(1), 232-237
50. Chaplan, S.R., Pogrel, J.W., Yaksh, T.L.(1994). Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 269(3), 1117-1123
51. Scott, D.A., Wright, C.E., Angus, J.A.(2002). Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur J Pharmacol 451(3), 279-286
52. Yamamoto, T., Sakashita, Y.(1998). Differential effects of intrathecally administered N-and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat. Brain Res 794(2), 329-332
53. Wang, Y.X., Pettus, M., Gao, D., Phillips, C., Scott Bowersox, S.(2000). Effects of intrathecal administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain. Pain 84(2-3), 151-158
54. Staats, P.S., Yearwood, T., Charapata, S.G., Presley, R.W., Wallace, M.S., Byas-Smith, M., Fisher, R., Bryce, D.A., Mangieri, E.A., Luther, R.R., Mayo, M., McGuire, D., Ellis, D.(2004). Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS, a randomized controlled trial. JAMA 291(1), 63-70
55. Wallace, M.S., Charapata, S.G., Fisher, R., Byas-Smith, M., Staats, P.S., Mayo, M., McGuire, D., Ellis, D.(2006). Intrathecal ziconotide in the treatment of chronic nonmalignant pain, a randomized, double-blind, placebo-controlled clinical trial. Neuromodulation 9(2), 75-86
56. Rauck, R.L., Wallace, M.S., Leong, M.S., Minehart, M., Webster, L.R., Charapata, S.G., Abraham, J.E., Buffington, D.E., Ellis, D., Kartzinel, R.(2006). A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 31(5), 393-406
57. Atanassoff, P.G., Hartmannsgruber, M.W., Thrasher, J., Wermeling, D., Longton, W., Gaeta, R., Singh, T., Mayo, M., McGuire, D., Luther, R.R.(2000). Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain. Reg Anesth Pain Med 25(3), 274-278
58. Brose, W.G., Gutlove, D.P., Luther, R.R., Bowersox, S.S., McGuire, D.(1997). Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain. Clin J Pain 13(3), 256-259
59. Wermeling, D., Drass, M., Ellis, D., Mayo, M., McGuire, D., O ' Connell, D., Hale, V., Chao, S.(2003). Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patients. J Clin Pharmacol 43(6), 624-636
60. Wermeling, D.P., Berger, J.R.(2006). Ziconotide infusion for severe chronic pain, case series of patients with neuropathic pain. Pharmacotherapy 26(3), 395-402
61. Fuertges, F., Abuchowski, A.(1990). The clinical efficacy of poly(ethylene glycol)-modified proteins. J Control Release 11(1-3), 139-148
62. Snutch, T.P.(2004). N-type channels, small organic molecules and pain. Spring Pain Research Conference. Grand Cayman, BWI, April 24-May 1
63. Snutch, T.P., Feng, Z.P., Belardetti, F., Vanderah, T., Zamponi, G.W., Porreca, F.(2003). Novel N-type calcium channel blockers efficacious in animal models of chronic pain. 226th American Chemical Society National Meeting. New York, September 7-11
64. Maneuf, Y.P., Luo, Z.D., Lee, K.(2006). Alpha2delta and the mechanism of action of gabapentin in the treatment of pain. Semin Cell Dev Biol 17(5), 565-570
65. Curran, M.P., Wagstaff, A.J.(2003). Gabapentin, in postherpetic neuralgia. CNS Drugs 17(13), 975-982
66. Morello, C.M., Leckband, S.G., Stoner, C.P., Moorhouse, D.F., Sahagian, G.A.(1999). Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159(16), 1931-1937
67. Cheshire, W.P., Jr.(2002). Defining the role for gabapentin in the treatment of trigeminal neuralgia, a retrospective study. J Pain 3(2), 137-142
68. Levendoglu, F., Ogun, C.O., Ozerbil, O., Ogun, T.C., Ugurlu, H.(2004). Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine 29(7), 743-751
69. Caraceni, A., Zecca, E., Bonezzi, C., Arcuri, E., Yaya Tur, R., Maltoni, M., Visentin, M., Gorni, G., Martini, C., Tirelli, W., Barbieri, M., De Conno, F.(2004). Gabapentin for neuropathic cancer pain, a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 22(14), 2909-2917
70. Yaksi, A., Ozgonenel, L., Ozgonenel, B.(2007). The efficiency of gabapentin therapy in patients with lumbar spinal stenosis. Spine 32(9), 939-942
71. Dworkin, R.H., Corbin, A.E., Young, J.P., Jr., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E.A., Poole, R.M.(2003). Pregabalin for the treatment of postherpetic neuralgia, a randomized, placebo-controlled trial. Neurology 60(8), 1274-1283
72. Lesser, H., Sharma, U., LaMoreaux, L., Poole, R.M.(2004). Pregabalin relieves symptoms of painful diabetic neuropathy, a randomized controlled trial. Neurology 63(11), 2104-2110
73. Rosenstock, J., Tuchman, M., LaMoreaux, L., Sharma, U.(2004). Pregabalin for the treatment of painful diabetic peripheral neuropathy, a double-blind, placebo-controlled trial. Pain 110(3), 628-638
74. Richter, R.W., Portenoy, R., Sharma, U., Lamoreaux, L., Bockbrader, H., Knapp, L.E.(2005). Relief of painful diabetic peripheral neuropathy with pregabalin, a randomized, placebo-controlled trial. J Pain 6(4), 253-260
75. Obermann, M., Yoon, M.S., Sensen, K., Maschke, M., Diener, H.C., Katsarava, Z.(2008). Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 28(2), 174-181
76. Crofford, L.J., Rowbotham, M.C., Mease, P.J., Russell, I.J., Dworkin, R.H., Corbin, A.E., Young, J.P., Jr., LaMoreaux, L.K., Martin, S.A., Sharma, U.(2005). Pregabalin for the treatment of fibromyalgia syndrome, results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52(4), 1264-1273
77. Field, M.J., Oles, R.J., Lewis, A.S., McCleary, S., Hughes, J., Singh, L.(1997). Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol 121(8), 1513-1522
78. Hunter, J.C., Gogas, K.R., Hedley, L.R., Jacobson, L.O., Kassotakis, L., Thompson, J., Fontana, D.J.(1997). The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324(2-3), 153-160
79. Christensen, D., Gautron, M., Guilbaud, G., Kayser, V.(2001). Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain. Pain 93(2), 147-153
80. Luo, Z.D., Calcutt, N.A., Higuera, E.S., Valder, C.R., Song, Y.H., Svensson, C.I., Myers, R.R.(2002). Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303(3), 1199-1205
81. Suman-Chauhan, N., Webdale, L., Hill, D.R., Woodruff, G.N.(1993). Characterisation of [3H]gabapentin binding to a novel site in rat brain, homogenate binding studies. Eur J Pharmacol 244(3), 293-301
82. Field, M.J., Cox, P.J., Stott, E., Melrose, H., Offord, J., Su, T.Z., Bramwell, S., Corradini, L., England, S., Winks, J., Kinloch, R.A., Hendrich, J., Dolphin, A.C., Webb, T., Williams, D.(2006). Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci U S A 103(46), 17537-17542
83. Gee, N.S., Brown, J.P., Dissanayake, V.U., Offord, J., Thurlow, R., Woodruff, G.N.(1996). The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 271(10), 5768-5776
84. McClelland, D., Evans, R.M., Barkworth, L., Martin, D.J., Scott, R.H.(2004). A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal rats. BMC Pharmacol 4(1), 14
85. Stefani, A., Spadoni, F., Bernardi, G.(1998). Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology 37(1), 83-91
86. Stefani, A., Spadoni, F., Giacomini, P., Lavaroni, F., Bernardi, G.(2001). The effects of gabapentin on different ligand-and voltage-gated currents in isolated cortical neurons. Epilepsy Res 43(3), 239-248
87. Alden, K.J., Garcia, J.(2001). Differential effect of gabapentin on neuronal and muscle calcium currents. J Pharmacol Exp Ther 297(2), 727-735
88. Martin, D.J., McClelland, D., Herd, M.B., Sutton, K.G., Hall, M.D., Lee, K., Pinnock, R.D., Scott, R.H.(2002). Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. Neuropharmacology 42(3), 353-366
89. Sutton, K.G., Martin, D.J., Pinnock, R.D., Lee, K., Scott, R.H.(2002). Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol 135(1), 257-265
90. Maneuf, Y.P., Blake, R., Andrews, N.A., McKnight, A.T.(2004). Reduction by gabapentin of K+-evoked release of [3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat. Br J Pharmacol 141(4), 574-579
91. Newton, R.A., Bingham, S., Case, P.C., Sanger, G.J., Lawson, S.N.(2001). Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta-1 subunit following partial sciatic nerve injury. Brain Res Mol Brain Res 95(1-2), 1-8
92. Abe, M., Kurihara, T., Han, W., Shinomiya, K., Tanabe, T.(2002). Changes in expression of voltage-dependent ion channel subunits in dorsal root ganglia of rats with radicular injury and pain. Spine 27(14), 1517-1524
93. Melrose, H.L., Kinloch, R.A., Cox, P.J., Field, M.J., Collins, D., Williams, D.(2007). [3H] pregabalin binding is increased in ipsilateral dorsal horn following chronic constriction injury. Neurosci Lett 417(2), 187-192
94. Luo, Z.D., Chaplan, S.R., Higuera, E.S., Sorkin, L.S., Stauderman, K.A., Williams, M.E., Yaksh, T.L.(2001). Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 21(6), 1868-1875
95. Li, C.Y., Zhang, X.L., Matthews, E.A., Li, K.W., Kurwa, A., Boroujerdi, A., Gross, J., Gold, M.S., Dickenson, A.H., Feng, G., Luo, Z.D.(2006). Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain 125(1-2), 20-34
96. Fehrenbacher, J.C., Taylor, C.P., Vasko, M.R.(2003). Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 105(1-2), 133-141
97. Bayer, K., Ahmadi, S., Zeilhofer, H.U.(2004). Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels. Neuropharmacology 46(5), 743-749
98. Coderre, T.J., Kumar, N., Lefebvre, C.D., Yu, J.S.(2005). Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 94(4), 1131-1139
99. Cribbs, L.L., Lee, J.H., Yang, J., Satin, J., Zhang, Y., Daud, A., Barclay, J., Williamson, M.P., Fox, M., Rees, M., Perez-Reyes, E.(1998). Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res 83(1), 103-109
100. Lee, J.H., Daud, A.N., Cribbs, L.L., Lacerda, A.E., Pereverzev, A., Klockner, U., Schneider, T., Perez-Reyes, E.(1999). Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. J Neurosci 19(6), 1912-1921
101. Perez-Reyes, E., Cribbs, L.L., Daud, A., Lacerda, A.E., Barclay, J., Williamson, M.P., Fox, M., Rees, M., Lee, J.H.(1998). Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature 391(6670), 896-900
102. Lee, J.H., Gomora, J.C., Cribbs, L.L., Perez-Reyes, E.(1999). Nickel block of three cloned T-type calcium channels, low concentrations selectively block alpha1H. Biophys J 77(6), 3034-3042
103. Gao, B., Sekido, Y., Maximov, A., Saad, M., Forgacs, E., Latif, F., Wei, M.H., Lerman, M., Lee, J.H., Perez-Reyes, E., Bezprozvanny, I., Minna, J.D.(2000). Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2). J Biol Chem 275(16), 12237-12242
104. Klugbauer, N., Dai, S., Specht, V., Lacinova, L., Marais, E., Bohn, G., Hofmann, F.(2000). A family of gamma-like calcium channel subunits. FEBS Lett 470(2), 189-197
105. Leuranguer, V., Bourinet, E., Lory, P., Nargeot, J.(1998). Antisense depletion of beta-subunits fails to affect T-type calcium channels properties in a neuroblastoma cell line. Neuropharmacology 37(6), 701-708
106. Scroggs, R.S., Fox, A.P.(1992). Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size. J Physiol 445 , 639-658
107. Scroggs, R.S., Fox, A.P.(1992). Multiple Ca2+ currents elicited by action potential waveforms in acutely isolated adult rat dorsal root ganglion neurons. J Neurosci 12(5), 1789-1801
108. Coulter, D.A., Huguenard, J.R., Prince, D.A.(1989). Calcium currents in rat thalamocortical relay neurones, kinetic properties of the transient, low-threshold current. J Physiol 414 , 587-604
109. Huguenard, J.R., Prince, D.A.(1992). A novel T-type current underlies prolonged Ca(2+)-dependent burst firing in GABAergic neurons of rat thalamic reticular nucleus. J Neurosci 12(10), 3804-3817
110. White, G., Lovinger, D.M., Weight, F.F.(1989). Transient low-threshold Ca2+ current triggers burst firing through an afterdepolarizing potential in an adult mammalian neuron. Proc Natl Acad Sci U S A 86(17), 6802-6806
111. Suzuki, S., Rogawski, M.A.(1989). T-type calcium channels mediate the transition between tonic and phasic firing in thalamic neurons. Proc Natl Acad Sci U S A 86(18), 7228-7232
112. Miller, R.J.(1987). Multiple calcium channels and neuronal function. Science 235(4784), 46-52
113. Kase, M., Kakimoto, S., Sakuma, S., Houtani, T., Ohishi, H., Ueyama, T., Sugimoto, T.(1999). Distribution of neurons expressing alpha 1G subunit mRNA of T-type voltage-dependent calcium channel in adult rat central nervous system. Neurosci Lett 268(2), 77-80
114. Talley, E.M., Cribbs, L.L., Lee, J.H., Daud, A., Perez-Reyes, E., Bayliss, D.A.(1999). Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci 19(6), 1895-1911
115. Todorovic, S.M., Jevtovic-Todorovic, V., Meyenburg, A., Mennerick, S., Perez-Reyes, E., Romano, C., Olney, J.W., Zorumski, C.F.(2001). Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron 31(1), 75-85
116. Nelson, M.T., Woo, J., Kang, H.W., Vitko, I., Barrett, P.Q., Perez-Reyes, E., Lee, J.H., Shin, H.S., Todorovic, S.M.(2007). Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels. J Neurosci 27(31), 8250-8260
117. Lambert, R.C., McKenna, F., Maulet, Y., Talley, E.M., Bayliss, D.A., Cribbs, L.L., Lee, J.H., Perez-Reyes, E., Feltz, A.(1998). Low-voltage-activated Ca2+ currents are generated by members of the CavT subunit family (alpha1G/H) in rat primary sensory neurons. J Neurosci 18(21), 8605-8613
118. Abdulla, F.A., Smith, P.A.(2001). Axotomy-and autotomy-induced changes in Ca2+ and K+ channel currents of rat dorsal root ganglion neurons. J Neurophysiol 85(2), 644-658
119. Hogan, Q.H., McCallum, J.B., Sarantopoulos, C., Aason, M., Mynlieff, M., Kwok, W.M., Bosnjak, Z.J.(2000). Painful neuropathy decreases membrane calcium current in mammalian primary afferent neurons. Pain 86(1-2), 43-53
120. McCallum, J.B., Kwok, W.M., Mynlieff, M., Bosnjak, Z.J., Hogan, Q.H.(2003). Loss of T-type calcium current in sensory neurons of rats with neuropathic pain. Anesthesiology 98(1), 209-216
121. McCallum, J.B., Kwok, W.M., Sapunar, D., Fuchs, A., Hogan, Q.H.(2006). Painful peripheral nerve injury decreases calcium current in axotomized sensory neurons. Anesthesiology 105(1), 160-168
122. Wen, X.J., Li, Z.J., Chen, Z.X., Fang, Z.Y., Yang, C.X., Li, H., Zeng, Y.M.(2006). Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotidereverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion. Acta Pharmacol Sin 27(12), 1547-1552
123. Bourinet, E., Alloui, A., Monteil, A., Barrere, C., Couette, B., Poirot, O., Pages, A., McRory, J., Snutch, T.P., Eschalier, A., Nargeot, J.(2005). Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24(2), 315-324
124. Choi, S., Na, H.S., Kim, J., Lee, J., Lee, S., Kim, D., Park, J., Chen, C.C., Campbell, K.P., Shin, H.S.(2007). Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels. Genes Brain Behav 6(5), 425-431
125. Kim, D., Park, D., Choi, S., Lee, S., Sun, M., Kim, C., Shin, H.S.(2003). Thalamic control of visceral nociception mediated by T-type Ca2+ channels. Science 302(5642), 117-119
126. Llinas, R.R., Ribary, U., Jeanmonod, D., Kronberg, E., Mitra, P.P.(1999). Thalamocortical dysrhythmia, a neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc Natl Acad Sci U S A 96(26), 15222-15227
127. McGivern, J.G.(2006). Pharmacology and drug discovery for T-type calcium channels. CNS Neurol Disord Drug Targets 5(6), 587-603
128. Gomora, J.C., Daud, A.N., Weiergraber, M., Perez-Reyes, E.(2001). Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol 60(5), 1121-1132
129. Todorovic, S.M., Lingle, C.J.(1998). Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons, effects of anticonvulsant and anesthetic agents. J Neurophysiol 79(1), 240-252
130. Coulter, D.A., Huguenard, J.R., Prince, D.A.(1989). Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol 25(6), 582-593
131. Leresche, N., Parri, H.R., Erdemli, G., Guyon, A., Turner, J.P., Williams, S.R., Asprodini, E., Crunelli, V.(1998). On the action of the anti-absence drug ethosuximide in the rat and cat thalamus. J Neurosci 18(13), 4842-4853
132. Matthews, E.A., Dickenson, A.H.(2001). Effects of ethosuximide, a T-type Ca(2+) channel blocker, on dorsal horn neuronal responses in rats. Eur J Pharmacol 415(2-3), 141-149
133. Gogas, K.R., Loo, C., Fellows, R., Lewis, R., Secchi, R., Thompson, J., Waligora, D., Jacobson, L., Zhu, Q., Hedley, L.R., Malmberg, A.B., Hunter, J.C., McGivern, J.G.(2002). Effects of the T-type calcium channel blocker, ethosuximide, in rodent models of acute and chronic pain. IASP 10th World Congress on Pain. San Diego, CA, August 17-22
134. Dogrul, A., Gardell, L.R., Ossipov, M.H., Tulunay, F.C., Lai, J., Porreca, F.(2003). Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 105(1-2), 159-168
135. Flatters, S.J., Bennett, G.J.(2004). Ethosuximide reverses paclitaxel-and vincristine-induced painful peripheral neuropathy. Pain 109(1-2), 150-161
136. Eggers, A.E., Moreno, H.(2002). Suggestion for another anti-epileptic drug to use for migraine prophylaxis. Headache 42(7), 696-697
137. Suzuki, S., Kawakami, K., Nishimura, S., Watanabe, Y., Yagi, K., Seino, M., Miyamoto, K.(1992). Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res 12(1), 21-27
138. Kito, M., Maehara, M., Watanabe, K.(1994). Antiepileptic drugs-calcium current interaction in cultured human neuroblastoma cells. Seizure 3(2), 141-149
139. Kito, M., Maehara, M., Watanabe, K.(1996). Mechanisms of T-type calcium channel blockade by zonisamide. Seizure 5(2), 115-119
140. Tanabe, M., Murakami, T., Ono, H.(2008). Zonisamide suppresses pain symptoms of formalin-induced inflammatory and streptozotocin-induced diabetic neuropathy. J Pharmacol Sci 107(2), 213-220
141. Hord, A.H., Denson, D.D., Chalfoun, A.G., Azevedo, M.I.(2003). The effect of systemic zonisamide (Zonegran) on thermal hyperalgesia and mechanical allodynia in rats with an experimental mononeuropathy. Anesth Analg 96(6), 1700-1706
142. Drake, M.E., Jr., Greathouse, N.I., Renner, J.B., Armentbright, A.D.(2004). Open-label zonisamide for refractory migraine. Clin Neuropharmacol 27(6), 278-280
143. Takahashi, Y., Hashimoto, K., Tsuji, S.(2004). Successful use of zonisamide for central poststroke pain. J Pain 5(3), 192-194
144. Randall, A.D., Tsien, R.W.(1997). Contrasting biophysical and pharmacological properties of T-type and R-type calcium channels. Neuropharmacology 36(7), 879-893
145. Arnoult, C., Villaz, M., Florman, H.M.(1998). Pharmacological properties of the T-type Ca2+ current of mouse spermatogenic cells. Mol Pharmacol 53(6), 1104-1111
146. Mishra, S.K., Hermsmeyer, K.(1994). Selective inhibition of T-type Ca2+ channels by Ro 40-5967. Circ Res 75(1), 144-148
147. Mehrke, G., Zong, X.G., Flockerzi, V., Hofmann, F.(1994). The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels. J Pharmacol Exp Ther 271(3), 1483-1488
148. Clozel, J.P., Ertel, E.A., Ertel, S.I.(1997). Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. J Hypertens Suppl 15(5), S17-S25
149. Leuranguer, V., Mangoni, M.E., Nargeot, J., Richard, S.(2001). Inhibition of T-type and L-type calcium channels by mibefradil, physiologic and pharmacologic bases of cardiovascular effects. J Cardiovasc Pharmacol 37(6), 649-661
150. Todorovic, S.M., Meyenburg, A., Jevtovic-Todorovic, V.(2002). Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker. Brain Res 951(2), 336-340
151. Cheng, J.K., Lin, C.S., Chen, C.C., Yang, J.R., Chiou, L.C.(2007). Effects of intrathecal injection of T-type calcium channel blockers in the rat formalin test. Behav Pharmacol 18(1), 1-8
152. Todorovic, S.M., Rastogi, A.J., Jevtovic-Todorovic, V.(2003). Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. Br J Pharmacol 140(2), 255-260.